Welcome to our dedicated page for ATMVW news (Ticker: ATMVW), a resource for investors and traders seeking the latest updates and insights on ATMVW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ATMVW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ATMVW's position in the market.
AlphaVest Acquisition Corp announced the pricing of its initial public offering of 6,000,000 units at $10.00 each. The units will be listed on Nasdaq under the ticker symbol ATMVU, trading begins on December 20, 2022. Each unit includes one ordinary share and one right for a fraction of a share upon a business combination. The offering, closing on December 22, 2022, focuses on acquiring businesses in Asia. EarlyBirdCapital, Inc. serves as the bookrunning manager. A 45-day underwriter option is also granted for an additional 900,000 units.
